• Version
  • Download 230
  • File Size 0.00 KB
  • File Count 1
  • Create Date November 19, 2020
  • Last Updated November 19, 2020

Economic evaluation of sequences of biological treatments for patients with moderate-to-severe Rheumatoid Arthritis and inadequate response or intolerance to Methotrexate in France

An economic evaluation for France of bDMARD sequences for treatment of moderate-to-severe RA after inadequate response or intolerance to conventional DMARDs (eg, methotrexate).

Attached Files